Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered question first ministerially corrected answering member label attachment file name title previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

90125

	registered interest
	date	01/09/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what payments have been received in the 2014-15 financial year by GPs for the delivery of vaccines through each routine immunisation programme, broken down by (a) item-of-service payment, (b) administration fee, (c) reimbursement cost, (d) Quality and Outcomes Framework reward and (e) Directed Enhanced Service payment; and if he will make a statement.
	tabling member constituency	Reigate
	tabling member printed	Crispin Blunt
	uin	207552
	answer	answer is ministerial correction date of answer 08/09/2014 answer text <p>Data for the current financial year <ins class="ministerial">are </ins><del class="ministerial"> is</del> not yet available. Financial data on overall spend of vaccination and immunisation programmes <ins class="ministerial">in general practice are </ins><del class="ministerial">is</del> published by the Health and Social Care Information Centre (HSCIC) <del class="ministerial">once it has undergone routine checks and audits as set by the National Audit Office</del>.</p><p> </p><p> </p><p> </p><p>HSCIC <del class="ministerial">will</del> publish<ins class="ministerial">ed</ins> the data for 2013-14 on <ins class="ministerial">19 </ins><del class="ministerial">22</del> September 2014.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 08/09/2014 14:40:24 question first ministerially corrected 28/10/2014 11:10:30 answering member 3918 label Biography information for Jane Ellison previous answer version 18802 answering member constituency Battersea answering member printed Jane Ellison answering member 3918 label Biography information for Jane Ellison
	tabling member	104 label Biography information for Crispin Blunt

61043

	registered interest
	date	10/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the uptake rate was of each (a) childhood vaccination, (b) vaccination for people aged 65 and over and (c) vaccination for people who fall into risk groups recommended by his Department as a proportion of the total eligible population for the vaccination, in each of the last 10 years.
	tabling member constituency	Reigate
	tabling member printed	Crispin Blunt
	uin	199984
	answer	answer is ministerial correction date of answer 17/06/2014 answer text <p>Much of the information requested is contained in “NHS Immunisation Statistics, England 2012-13” published by the Health and Social Care Information Centre (HSCIC) on 26 September 2013. This provides vaccine uptake rates for routine childhood vaccinations. It also contains more limited information on the uptake of adult influenza immunisations. The report provides uptake information covering the period from 2002-03 to 2012-13. Tables 1 to 3 on pages 54 to 55 are particularly pertinent to the question. A copy of the HSCIC report has been placed in the Library.</p><p> </p><p>Additional information on vaccine uptake which is not contained in the HSCIC report is set out as follows.</p><p> </p><p>(a) Childhood vaccination. Immunisation is offered to girls aged 12-13 to protect against the human papillomavirus (HPV) virus which can cause cervical cancer. Uptake of HPV vaccination from 2008-09, when it was introduced, is set out in Table 1. Figures for 2013-14 are not yet available.</p><p> </p><p>Table 1: Annual HPV vaccine uptake for females aged 12 to 13 years (England)</p><p> </p><table><tbody><tr><td><p>Academic year</p></td><td> </td><td><p>Uptake %</p></td></tr><tr><td rowspan="3"><p>2008/09</p></td><td><p>At least 1 dose</p></td><td><p>88.1</p></td></tr><tr><td><p>At least 2 doses</p></td><td><p>86.0</p></td></tr><tr><td><p>3 doses</p></td><td><p>80.1</p></td></tr><tr><td rowspan="3"><p>2009/10</p></td><td><p>At least 1 dose</p></td><td><p>84.3</p></td></tr><tr><td><p>At least 2 doses</p></td><td><p>82.3</p></td></tr><tr><td><p>3 doses</p></td><td><p>76.4</p></td></tr><tr><td rowspan="3"><p>2010/11</p></td><td><p>At least 1 dose</p></td><td><p>88.9</p></td></tr><tr><td><p>At least 2 doses</p></td><td><p>87.5</p></td></tr><tr><td><p>3 doses</p></td><td><p>84.2</p></td></tr><tr><td rowspan="3"><p>2011/12</p></td><td><p>At least 1 dose</p></td><td><p>90.6</p></td></tr><tr><td><p>At least 2 doses</p></td><td><p>89.6</p></td></tr><tr><td><p>3 doses</p></td><td><p>86.8</p></td></tr><tr><td rowspan="3"><p>2012/13</p></td><td><p>At least 1 dose</p></td><td><p>90.9</p></td></tr><tr><td><p>At least 2 doses</p></td><td><p>89.6</p></td></tr><tr><td><p>3 doses</p></td><td><p>86.1</p></td></tr></tbody></table><p>Immunisation against influenza is offered to children with certain clinical conditions which put them at greater risk of the effects of influenza. Vaccine uptake is set out in Table 2.</p><p> </p><p>Table 2: Annual influenza vaccine uptake for children with clinical conditions aged 6 months to under16 years (England)</p><p> </p><table><tbody><tr><td> </td><td><p>Children aged 6 months to 2 years with clinical condition. Vaccine Uptake</p><p>%</p></td><td><p>Children aged 2 to under 16 years with clinical condition.</p><p>Vaccine Uptake</p><p>%</p></td></tr><tr><td><p>2006/07</p></td><td><p>6.2</p></td><td><p>22.3</p></td></tr><tr><td><p>2007/08</p></td><td><p>6.2</p></td><td><p>22.3</p></td></tr><tr><td><p>2008/09</p></td><td><p>7.3</p></td><td><p>23.8</p></td></tr><tr><td><p>2009/10</p></td><td><p>16.5</p></td><td><p>34.5</p></td></tr><tr><td><p>2010/11</p></td><td><p>25.2</p></td><td><p>39.3</p></td></tr><tr><td><p>2011/12</p></td><td><p>22.5</p></td><td><p>38.3</p></td></tr><tr><td><p>2012/13</p></td><td><p>24.3</p></td><td><p>38.7</p></td></tr><tr><td><p>2013/14</p></td><td><p>24.2</p></td><td><p>42.6</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p>In September 2013 vaccination of healthy two and three year old children against influenza was introduced. From September 2013 to January 2014 42.6% of two year old children, and 39.5% of three year old children were vaccinated.</p><p> </p><p>(b) People aged 65 and over. Influenza vaccination is offered to this group. Vaccine uptake is set out in Table 3.</p><p> </p><p>Table 3: Annual influenza vaccine uptake for people aged 65 or over (England)</p><p> </p><table><tbody><tr><td> </td><td><p>Vaccine Uptake (%)</p></td></tr><tr><td><p>2004/05</p></td><td><p>71.4</p></td></tr><tr><td><p>2005/06</p></td><td><p>75.3</p></td></tr><tr><td><p>2006/07</p></td><td><p>73.9</p></td></tr><tr><td><p>2007/08</p></td><td><p>73.5</p></td></tr><tr><td><p>2008/09</p></td><td><p>74.1</p></td></tr><tr><td><p>2009/10</p></td><td><p>72.4</p></td></tr><tr><td><p>2010/11</p></td><td><p>72.8</p></td></tr><tr><td><p>2011/12</p></td><td><p>74.0</p></td></tr><tr><td><p>2012/13</p></td><td><p>73.4</p></td></tr><tr><td><p>2013/14</p></td><td><p>73.2</p></td></tr></tbody></table><p> </p><p>Immunisation is also offered against pneumococcal disease. The figures in Table 4 show the percentage of the population who have ever received a pneumococcal disease vaccine (PPV) since the age of 65. Figures for 2013-14 are not yet available.</p><p> </p><p>Table 4: PPV uptake for people aged 65 or over (England)</p><p> </p><table><tbody><tr><td> </td><td><p>Vaccine Uptake (%)</p></td></tr><tr><td><p>2005/06</p></td><td><p>64.4</p></td></tr><tr><td><p>2006/07</p></td><td><p>66.6</p></td></tr><tr><td><p>2007/08</p></td><td><p>69.0</p></td></tr><tr><td><p>2008/09</p></td><td><p>68.2</p></td></tr><tr><td><p>2009/10</p></td><td><p>69.4</p></td></tr><tr><td><p>2010/11</p></td><td><p>70.5</p></td></tr><tr><td><p>2011/12</p></td><td><p>68.3</p></td></tr><tr><td><p>2012/13</p></td><td><p>69.1</p></td></tr></tbody></table><p> </p><p>(c) People in risk groups. Influenza vaccination has been offered to all pregnant women since the 2010/11 flu season. Vaccine uptake is set out in Table 5.</p><p> </p><p>Table 5: Annual influenza vaccine uptake for all pregnant women (England)</p><p> </p><table><tbody><tr><td> </td><td><p>Vaccine Uptake (%)</p></td></tr><tr><td><p>2010/11</p></td><td><p>38.0</p></td></tr><tr><td><p>2011/12</p></td><td><p>27.4</p></td></tr><tr><td><p>2012/13</p></td><td><p>40.3</p></td></tr><tr><td><p>2013/14</p></td><td><p>39.8</p></td></tr></tbody></table><p> </p><p>Influenza vaccination is also offered to people with certain clinical conditions which put them at greater risk of the effects of influenza. Vaccine uptake is set out in Table 6.</p><p> </p><p>Table 6: Annual influenza vaccine uptake for people with clinical conditions aged 16 to under 65 years (England)</p><p> </p><table><tbody><tr><td> </td><td><p>Vaccine Uptake (%)</p></td></tr><tr><td><p>2006/07</p></td><td><p>45.1</p></td></tr><tr><td><p>2007/08</p></td><td><p>48.6</p></td></tr><tr><td><p>2008/09</p></td><td><p>50.2</p></td></tr><tr><td><p>2009/10</p></td><td><p>53.6</p></td></tr><tr><td><p>2010/11</p></td><td><p>51.7</p></td></tr><tr><td><p>2011/12</p></td><td><p>53.2</p></td></tr><tr><td><p>2012/13</p></td><td><p>52.8</p></td></tr><tr><td><p>2013/14</p></td><td><p>53.4</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 17/06/2014 16:00:00 answering member 3918 label Biography information for Jane Ellison attachment 1 file name PQ199984 - Lib Doc - Report.pdf title NHS Immunisation Statistics
	tabling member	104 label Biography information for Crispin Blunt

61044

	registered interest
	date	10/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Pneumococcal Disease: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment he has made of the availability of pneumococcal vaccine to (a) children, (b) adults under the age of 65 in at-risk groups and (c) adults over the age of 65; and if he will make a statement.
	tabling member constituency	Reigate
	tabling member printed	Crispin Blunt
	uin	199986
	answer	answer is ministerial correction date of answer 17/06/2014 answer text <p>The objective of the immunisation programme against pneumococcal infection is to protect individuals for whom such infection is likely to be more common and/or serious. The following groups are eligible for vaccination under the national immunisation programme:</p><p> </p><p>- infants as part of the routine childhood immunisation programme;</p><p>- those aged 65 years or over; and</p><p>- children and adults in the clinical risk groups.</p><p>We are not aware of any supply problems with pneumococcal vaccines.</p><p><strong> </strong></p><p>The levels of uptake of pneumococcal vaccines are high. Latest uptake figures show that 94.4% of children in England had completed a primary immunisation course of pneumococcal conjugate vaccine at 12 months of age in 2012-13. This compares with 94.2% in 2011-12. Corresponding figures in adults aged 65 years or over for pneumococcal polysaccharide vaccine was 69.1% in 2012-13 compared to 68.3% in 2011-12.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 17/06/2014 16:14:17 answering member 3918 label Biography information for Jane Ellison
	tabling member	104 label Biography information for Crispin Blunt

61045

	registered interest
	date	10/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what plans (a) NHS England and (b) Public Health England have to fund awareness campaigns to increase vaccination uptake rates.
	tabling member constituency	Reigate
	tabling member printed	Crispin Blunt
	uin	199989
	answer	answer is ministerial correction date of answer 17/06/2014 answer text <p>Public Health England (PHE) is responsible for awareness campaigns for immunisation and keeps these matters under close review.</p><p> </p><p>Immunisation is one of the key behaviours under Start4Life - PHE's programme to help parents give their children the best start in life, from pregnancy up to 5 years of age. Immunisation is promoted on the Start4Life website and within the Start4Life Information for Parents emails and text messages.</p><p> </p><p>NHS England has no plans to fund national awareness campaigns for immunisation programmes.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 17/06/2014 15:54:36 answering member 3918 label Biography information for Jane Ellison
	tabling member	104 label Biography information for Crispin Blunt

61046

	registered interest
	date	10/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether NHS England plans to commission immunisation services through the any qualified provider procurement model.
	tabling member constituency	Reigate
	tabling member printed	Crispin Blunt
	uin	199990
	answer	answer is ministerial correction date of answer 17/06/2014 answer text <p>NHS England's Area Teams are already free to commission provision of immunisation services as they see fit in accordance with relevant legislation, to ensure that immunisation services are safe, effective, and of high quality. For example, NHS England commissions community pharmacies as supplementary providers of seasonal influenza immunisation.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 17/06/2014 16:19:25 answering member 3918 label Biography information for Jane Ellison
	tabling member	104 label Biography information for Crispin Blunt

61047

	registered interest
	date	10/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Influenza: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he has taken following his Department's consultation on a review of the procurement of seasonal infuenza vaccine in May 2011.
	tabling member constituency	Reigate
	tabling member printed	Crispin Blunt
	uin	199991
	answer	answer is ministerial correction date of answer 17/06/2014 answer text <p>No changes have been made since the consultation to procurement of vaccine for the existing seasonal flu programme, which are ordered directly by general practitioners from manufacturers or suppliers. However, vaccine for the programme for children aged two to 16 years, which began in 2013 and is being rolled out progressively, has been centrally procured. Experience of the childhood flu immunisation programme will help inform consideration of arrangements for procurement of influenza vaccine more widely.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 17/06/2014 16:30:15 answering member 3918 label Biography information for Jane Ellison
	tabling member	104 label Biography information for Crispin Blunt

61049

	registered interest
	date	10/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment (a) he and (b) NHS England have made of the consistency of NHS England's commissioning of immunisation services in different areas of the country; what plans NHS England has to conduct such an assessment in the future; and if he will make a statement.
	tabling member constituency	Reigate
	tabling member printed	Crispin Blunt
	uin	199987
	answer	answer is ministerial correction date of answer 17/06/2014 answer text <p>NHS England and Public Health England completed a joint stocktake review of the screening and immunisation services commissioned by NHS England earlier this year. The Department will discuss the findings of the review with NHS England in relation to the NHS public health functions agreement, including steps to bring services consistently into line with their national specifications.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 17/06/2014 16:15:48 answering member 3918 label Biography information for Jane Ellison
	tabling member	104 label Biography information for Crispin Blunt

61050

	registered interest
	date	10/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Pneumococcal Disease: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, for what reasons the Statement of Financial Entitlements for the pneumococcal vaccination Directed Enhanced Service for aged 65 years and over and for at-risk groups does not include a national payment scheme.
	tabling member constituency	Reigate
	tabling member printed	Crispin Blunt
	uin	199985
	answer	answer is ministerial correction date of answer 17/06/2014 answer text <p>The Directed Enhanced Service requires NHS England to establish a programme of pneumococcal vaccination for persons aged 65 years and over and to enter into arrangements with any primary medical services provider. It is for NHS England to determine the payments for this service. NHS England has agreed a national payment of £7.64 per dose for General Medical Services and Personal Medical Services providers for delivering the programme. The national specification is currently being finalised and will be published in due course.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 17/06/2014 16:02:10 answering member 3918 label Biography information for Jane Ellison
	tabling member	104 label Biography information for Crispin Blunt

61051

	registered interest
	date	10/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will publish detailed expenditure by NHS England on vaccination and immunisation services in 2013-14.
	tabling member constituency	Reigate
	tabling member printed	Crispin Blunt
	uin	199988
	answer	answer is ministerial correction date of answer 17/06/2014 answer text <p>We will publish later this year available information about expenditure on the National Health Service public health programmes commissioned by NHS England, including national immunisation programmes. The NHS public health functions agreement with NHS England describes the required breakdown of expenditure which does not include detailed expenditure for immunisation programmes.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 17/06/2014 15:53:33 answering member 3918 label Biography information for Jane Ellison
	tabling member	104 label Biography information for Crispin Blunt

61052

	registered interest
	date	10/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps NHS England is taking to reduce inequalities in access to immunisation programmes.
	tabling member constituency	Reigate
	tabling member printed	Crispin Blunt
	uin	199993
	answer	answer is ministerial correction date of answer 17/06/2014 answer text <p>Reduction of health inequalities is a service delivery requirement in the national service specifications for immunisation services under the National Health Service public health functions agreement between the Secretary of State and NHS England and is monitored by Area Teams in contract reviews with providers.</p><p><strong> </strong></p><p>NHS England's Area Teams seek to reduce inequalities in access to immunisation programmes at local level and improve engagement with groups that do not readily access health services, working in partnership with key stakeholders through health needs assessments and the joint strategic needs assessments used by the health and wellbeing boards.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 17/06/2014 16:25:16 answering member 3918 label Biography information for Jane Ellison
	tabling member	104 label Biography information for Crispin Blunt